Diyabet ile İlişkili Kronik Yarada Hiperbarik Oksijen Tedavisi
Özet
Diyabet, vaskülopati ve nöropati gibi mekanizmalarla doku bütünlüğünü bozarak özellikle alt ekstremitelerde iyileşmesi güç kronik yaralara yol açan önemli bir sağlık sorunudur. Bu süreçte gelişen doku hipoksisi, enfeksiyon riskini artırarak uzuv kaybı ve sepsis gibi ağır mortalite nedenlerine zemin hazırlar. Medikal ve cerrahi standart tedavilerin yetersiz kaldığı durumlarda yardımcı bir yöntem olarak öne çıkan Hiperbarik Oksijen Tedavisi (HBOT), hastaya basınç odasında %100 oksijen solutulması esasına dayanır. Henry gaz kanununa göre plazmada çözünen oksijeni artırarak derin dokulardaki hipoksiyi hızla gideren HBOT; neovaskülarizasyonu tetikler, ödemi azaltır, fibroblast proliferasyonunu artırır ve bağışıklık sistemini destekler. Klinik çalışmalar, uygun hasta seçiminde HBOT'nin amputasyon oranlarını düşürdüğünü ve yara iyileşmesini hızlandırdığını ortaya koysa da, eşlik eden komorbiditeler başarısını etkileyebilmektedir. Sonuç olarak, ulusal ve uluslararası kılavuzlarca da desteklenen bu tedavi, osteomyelit ve nekrotizan fasiitis gibi dirençli olgularda multidisipliner yara yönetiminin kritik bir parçasıdır.
Diabetes is a significant health problem that disrupts tissue integrity through mechanisms such as vasculopathy and neuropathy, leading to chronic wounds that are difficult to heal, particularly in the lower extremities. The resulting tissue hypoxia increases infection risks, paving the way for severe mortality causes like limb loss and sepsis. Hyperbaric Oxygen Therapy (HBOT), which stands out as an adjunctive method when standard medical and surgical treatments are insufficient, is based on breathing 100% oxygen in a pressurized chamber. By increasing dissolved oxygen in plasma according to Henry's gas law, HBOT rapidly relieves hypoxia in deep tissues; it triggers neovascularization, reduces edema, increases fibroblast proliferation, and supports the immune system. Although clinical studies reveal that HBOT reduces amputation rates and accelerates wound healing in appropriate patient selection, accompanying comorbidities can affect its success. Consequently, supported by national and international guidelines, this therapy is a critical part of multidisciplinary wound management in resistant cases like osteomyelitis and necrotizing fasciitis.
Referanslar
Saltoglu N, Kilicoglu O, Baktiroglu S, Osar-Siva Z, Aktas S, Altindas M, Arslan C, Aslan T, Celik S, Engin A, Eraksoy H. Diagnosis, treatment and prevention of diabetic foot wounds and infections: Turkish consensus report. Klimik Journal. 2015;28(1). doi:10.5152/kd.2015.29
Larsson J, Agardh CD, Apelqvist J, Stenström A. Long-term prognosis after healed amputation in patients with diabetes. Clinical orthopaedics and related research. 1998 May 1(350):149-58. PMID: 9602814.
Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers. Diabetes/metabolism research and reviews. 2004 May;20(S1):S78-89. doi:10.1002/dmrr.476
Armstrong DG, Boulton AJ, Bus SA. Diabetic foot ulcers and their recurrence. New England Journal of Medicine. 2017 Jun 15;376(24):2367-75. doi: 10.1056/NEJMra1615439
Jeffcoate WJ, Harding KG. Diabetic foot ulcers. The lancet. 2003 May 3;361(9368):1545-51.doi: 10.1016/S0140-6736(03)13169-8
Kirsner RS, Warriner 3rd RA, Lavery LA, Hanft JR, Sheehan P. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Snyder RJ, editor. HMP Communications; 2010 Apr 1. PMID: 20424290.
Amin N, Doupis J. Diabetic foot disease: from the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World journal of diabetes. 2016 Apr 10;7(7):153.doi: 10.4239/wjd.v7.i7.153
Gunther SF, Gunther SB. Diabetic hand infections. Hand clinics. 1998 Nov 1;14(4):647-56. PMID: 9884901.
Papanas N, Maltezos E. The diabetic hand: a forgotten complication?. Journal of Diabetes and its Complications. 2010 May 1;24(3):154-62. doi: 10.1016/j.jdiacomp.2008.12.009
Aydin F, Kaya A, Savran A, Incesu M, Karakuzu C, Ozturk AM. Diabetic hand infections and hyperbaric oxygen therapy. Acta Orthop Traumatol Turc. 2014 Nov 1;48(6):649-54.doi: 10.3944/AOTT.2014.3225
Ennis WJ, Huang ET, Gordon H. Impact of hyperbaric oxygen on more advanced wagner grades 3 and 4 diabetic foot ulcers: matching therapy to specific wound conditions. Advances in wound care. 2018 Dec 1;7(12):397-407.doi: 10.1089/wound.2018.0855.
Broussard CL. Hyperbaric oxygenation and wound healing. Journal of vascular Nursing. 2004 Jun 1;22(2):42-8.doi: 10.1016/j.jvn.2004.03.001
Thom SR. Hyperbaric oxygen–its mechanisms and efficacy. Plastic and reconstructive surgery. 2011 Jan;127(Suppl 1):131S. Doi: 10.1097/PRS.0b013e3181fbe2bf
Gill AÁ, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Qjmed. 2004 Jul 1;97(7):385-95.doi: 10.1093/qjmed/hch074
Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. Journal of postgraduate medicine. 1992 Jul 1;38(3):112. PMID: 1303408.
Tepić S, Petković A, Srejović I, Jeremić N, Zivković V, Loncarević S, Bradić J, Jakovljević V, Zivkovć M. Impact of hyperbaric oxygenation on oxidative stress in diabetic patients. Undersea & Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society, Inc. 2018 Jan 1;45(1):9-17. PMID: 29571227.
Kessler L, Bilbault P, ORTega FR, Grasso C, Passemard R, Stephan D, Pinget M, Schneider F. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes care. 2003 Aug 1;26(8):2378-82.doi: 10.2337/diacare.26.8.2378
Wattel F, Mathieu D, Coget JM, Billard V. Hyperbaric oxygen therapy in chronic vascular wound management. Angiology. 1990 Jan;41(1):59-65.doi: 10.1177/000331979004100109
Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, Michael M, Campagnoli P, Morabito A. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes care. 1996 Dec 1;19(12):1338-43. doi: 10.2337/diacare.19.12.1338
Zamboni WA, Wong HP, Stephenson LL, Pfeifer MA. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea & hyperbaric medicine: journal of the Undersea and Hyperbaric Medical Society, Inc. 1997 Sep 1;24(3):175-9. PMID: 9308140.
Löndahl M. Hyperbaric oxygen therapy as adjunctive treatment for diabetic foot ulcers. The International Journal of Lower Extremity Wounds. 2013 Jun;12(2):152-7.doi: 10.1016/j.mcna.2013.04.004
Santema KT, Stoekenbroek RM, Koelemay MJ, Reekers JA, Van Dortmont LM, Oomen A, Smeets L, Wever JJ, Legemate DA, Ubbink DT. Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care. 2018 Jan 1;41(1):112-9. doi: 10.2337/dc17-0654
Mutluoglu M, Uzun G, Bennett M, Germonpré P, Smart D, Mathieu D. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers. Diving and hyperbaric medicine. 2016 Sep 1;46(3):133-4. PMID: 27723012.
Akgül EA, Karakaya J, Aydın S. Role of comorbidities as limiting factors to the effect of hyperbaric oxygen in diabetic foot patients: a retrospective analysis. Diabetes Therapy. 2014 Dec;5(2):535-44. doi: 10.1007/s13300-014-0085-8
Rayman G, Vas P, Dhatariya K, Driver V, Hartemann A, Londahl M, Piaggesi A, Apelqvist J, Attinger C, Game F, International Working Group on the Diabetic Foot (IWGDF). Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update). Diabetes/metabolism research and reviews. 2020 Mar;36:e3283. doi:10.1002/dmrr.3283
Malhotra R, Chan CS, Nather A. Osteomyelitis in the diabetic foot. Diabetic Foot & Ankle. 2014 Jan 1;5(1):24445.doi: 10.3402/dfa.v5.24445.
Huang ET, Mansouri J, Murad MH, Joseph WS, Strauss MB, Tettelbach W, Worth ER; UHMS CPG Oversight Committee. A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Undersea Hyperb Med. 2015 May-Jun;42(3):205-47. PMID: 26152105.
Takazawa K, Otsuka H, Nakagawa Y, Inokuchi S. Clinical features of non-clostridial gas gangrene and risk factors for in-hospital mortality. Tokai J Exp Clin Med. 2015 Sep 20;40(3):124-9. PMID: 26369267.
Cheng NC, Tai HC, Chang SC, Chang CH, Lai HS. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC infectious diseases. 2015 Dec;15(1):1-9. PMID: 26369267.
Leiblein M, Wagner N, Adam EH, Frank J, Marzi I, Nau C. Clostridial Gas Gangrene‐A Rare but Deadly Infection: Case series and Comparison to Other Necrotizing Soft Tissue Infections. Orthopaedic Surgery. 2020 Dec;12(6):1733-47. doi:10.1111/os.12804
